We finally have a resolution to the takeover of Allergan and boy did we benefit as shareholders. After a long battle against Bill Ackman and Valeant Pharmaceuticals that began with a takeover offer in April, Allergan has decided to accept a “friendly” takeover offer from Actavis for $219/share valued at $66 billion. I was initially…